C4 Therapeutics, Inc. short interest in 2021
In 2021, C4 Therapeutics, Inc.'s disclosed short interest ran from 4.20% of shares outstanding on 15 Jan 2021 to 6.53% on 31 Dec 2021, a change of +2.33 percentage points. The year's high was 8.51% on 31 Mar 2021 and its low 3.58% on 29 Jan 2021, averaging 5.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.95 days on 29 Oct 2021. Full history: C4 Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 4.20% (15 Jan 2021)
- End of year
- 6.53% (31 Dec 2021)
- Change
- +2.33 pp
- High
- 8.51% (31 Mar 2021)
- Low
- 3.58% (29 Jan 2021)
- Average
- 5.60%
- Highest days to cover
- 17.95 (29 Oct 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 4.20% | 9.19 | results (8-K) |
| 29 Jan 2021 | 3.58% | 9.68 | |
| 12 Feb 2021 | 3.71% | 14.83 | |
| 26 Feb 2021 | 4.52% | 11.07 | |
| 15 Mar 2021 | 4.79% | 11.14 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 8.51% | 9.63 | |
| 15 Apr 2021 | 6.88% | 5.96 | |
| 30 Apr 2021 | 6.05% | 10.42 | |
| 14 May 2021 | 6.16% | 11.12 | 10-Q filed, results (8-K) |
| 28 May 2021 | 5.68% | 6.46 | |
| 15 Jun 2021 | 5.47% | 5.02 | |
| 30 Jun 2021 | 6.48% | 2.87 | |
| 15 Jul 2021 | 6.15% | 8.90 | |
| 30 Jul 2021 | 6.15% | 7.65 | |
| 13 Aug 2021 | 5.65% | 7.04 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 5.00% | 10.43 | |
| 15 Sep 2021 | 4.68% | 6.27 | |
| 30 Sep 2021 | 5.50% | 6.25 | |
| 15 Oct 2021 | 5.48% | 11.60 | |
| 29 Oct 2021 | 5.58% | 17.95 | |
| 15 Nov 2021 | 5.69% | 13.26 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 5.69% | 12.63 | |
| 15 Dec 2021 | 6.18% | 7.51 | |
| 31 Dec 2021 | 6.53% | 7.23 |
See also: C4 Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.